Best in 7 days
Pay in installments of $6.44 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jun 18 - Jun 23
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
https: bit.ly 45UTcvJ Attention Zepbound Users! Starting July 1, 2025, CVS Caremark will drop coverage for Zepbound (tirzepatide) and switch to Wegovy (semaglutide) as the preferred weight loss medication. Why this matters: How Menopause and ADHD Medications Affect Weight Loss Dr. Janelle Duah GLP 1 in Joints Suggests Arthritis Treatment Potential Does Zepbound need to be refrigerated? Eli Lilly just issued a public warning to the compounding industry. In a recent open letter, the pharmaceutical company raised concerns about tirzepatide products being combined with vitamin B12 and marketed in
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Discover Niche Categories That Outsell tirzepatide online for weight loss
Top-Converting Item to Boost Your Average Order
Best in 7 days
Best in 7 days
Best in 7 days
Best in 7 days
4.6 ★★★★★
Based on 2479 reviews
Sort
Product Reviews
★★★★★ 5
Cute and comfortable.
My son loves them. He's only worn them three times so I can't say yet how they hold up. But he's happy. My only wish is that the laces were a little longer so that he could have an easier time tying them. They do also come with an extra pair of turquoise laces.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 15, 2023
★★★★★ 5
saucony for life, kidz.
Color: Navy/Silver/Pink, Size: 7 Big Kid, Color: Navy/Silver/Pink, Size: 7 Big Kid
… why I appreciate being an adult female with average-sized feet, Especially considering kids’ shoes are always way cooler!
The sizing is a bit wonky, I’m normally a women’s 8, EU 39 which were my last saucony’s ,
These were exchanged after buying the “big kid 7” (too big),
after replacing w the 6.5 (38.5 EU) I still wondered about sizing down more but I think they’re good, they just fit differently than my previous ones… also I replaced the very long blue laces (48”) with shorter white ones (40”), and now I’m keeping and loving the shoes!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 6, 2025
★★★★★ 3
Runs Narrow
Color: Blue/White, Size: 1 Big Kid
They seem to run quite narrow, for my son who wears a medium comfortably. The New Balance fit much better.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 4, 2021
★★★★★ 5
Saucony
Size: 3.5 Big Kid, Color: Silver/Purple
Bellas
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 16, 2026
★★★★★ 5
Comfortable boy shoes
Size: 4 Wide Big Kid, Color: Black/White
My son’s favorite sneakers. I think this is a fourth pair we ordered as he grows. Lightweight but mostly wide enough to be comfortable. I wouldn’t buy them for a full price but they are often in sale and then it’s great value for my money.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 5, 2025
recommand products
how much does ww glp 1 cost KFF Health Tracking Poll May 2024: The Public's Use
27.48
GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness
22.11
GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity
22.17
Ground News | Federal regulators approved Eli Lilly's new weight-loss pill, orforglipron, giving patients a second daily oral GLP-1 treatment for obesity
29.19
Lilly's weight-loss drug reduces sleep apnea severity in late-stage trials
22.83